Lhasa Limited shared knowledge shared progress


Jump to results
Publication Type
Publication Year
Related Products
New search
Publications search results
Are All Nitrosamines Concerning?pdf fileVitic
Are all nitrosamines concerning? A review of mutagenicity and carcinogenicity dataDerek NexusLhasa Carcinogenicity DatabaseSarah NexusVitic
Automated chromophore identification to support prediction of light-mediated reactivitypdf fileZeneth
Case study on the use of integrated approaches to testing and assessment for the prediction of a 90-day repeated dose toxicity study (OECD 408) for 2-Ethylbutyric acid using a read-across approach from other branched carboxylic acids.
Chapter 17: Use of Lhasa Limited Products for the In Silico Prediction of Drug ToxicityDerek NexusSarah NexusMirabilisZeneth
Chapter 7: Compound- and Class-Specific Limits for Common Impurities in PharmaceuticalsDerek NexusSarah NexusLhasa Carcinogenicity DatabaseMirabilisAI/PDE Data Sharing Project
Collaborative analysis of complex nitrosaminespdf fileComplex Nitrosamines
Computational methods for the ground-state local electrophilicity-based prediction of hapten-protein interactionspdf file
Developing structure-activity relationships for N-nitrosamine activityDerek Nexus
Do all nitrosamines pose a significant level of genotoxic risk? (Webinar Presentation Slides)pdf fileDerek NexusLhasa Carcinogenicity DatabaseSarah Nexus
Flavours in Aromaticitypdf file
In Silico Prediction Of Excess Reactive Oxygen Species Generation By Metabolic Oxidation-Reduction Cycling Of Hydroquinonespdf file
Machine Learning Predicts Degree of Aromaticity from Structural Fingerprints
Predicting N-Nitrosamine Activity from SARpdf fileDerek NexusSarah NexusLhasa Carcinogenicity DatabaseNitrites in Excipients
Predicting Regioselectivity of AO, CYP, FMO, and UGT Metabolism Using Quantum Mechanical Simulations and Machine Learning
QSAR 2021 Addressing the global challenge of N-nitrosamine impurity assessmentpdf fileDerek NexusMirabilisSarah NexusVitic
QSAR 2021 Is the bacterial reverse mutation assay an accurate predictor for N-nitrosamine carcinogenicitypdf fileVitic
Quantifying confidence in the reporting of metabolic biotransformationsMeteor Nexus
Strategies for Assessing Acceptable Intakes for Novel N-Nitrosamines Derived from Active Pharmaceutical Ingredients
Structural features affecting nitrosamine carcinogenic potencypdf file
The Landscape of Potential Small and Drug Substance Related Nitrosamines in PharmaceuticalsComplex Nitrosamines
Updated Dermal Sensitisation Thresholds derived using an in silico expert system and an expanded Local Lymph Node Assay datasetpdf fileDerek Nexus
Updating the Dermal Sensitisation Thresholds using an expanded dataset and an in silico expert systemDerek Nexus
Use of less-than-lifetime (LTL) durational limits for nitrosamines: Case study of N-Nitrosodiethylamine (NDEA)
Utilisation of parametric methods to improve percentile-based estimates for the carcinogenic potency of nitrosaminesLhasa Carcinogenicity Database

© 2023 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).